One of the controlling shareholders of Jiangsu Aidea Pharmaceutical Group (688488.SH), Fu Heliang, intends to increase his shareholding in the company by 10 to 15 million yuan.

17:05 01/03/2026

Eddie Pharmaceutical (688488.SH) announced that one of the company's actual controllers and chairman, Mr. Fu Heliang (referred to as the "increasing holding entity" below), plans to increase the company's shares by means permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding and block trading) from March 2, 2026, for a period of 6 months. The planned amount of increase is not less than RMB 10 million (inclusive) and not more than RMB 15 million (inclusive).

Jiangsu Aidea Pharmaceutical Group (688488.SH) announced that one of the actual controllers and chairman, Mr. Fu Heliang (referred to hereafter as the "subject of increase holding"), plans to increase the company's shares through the Shanghai Stock Exchange trading system allowed method (including but not limited to centralized bidding and bulk trading) starting from March 2, 2026, for a period of 6 months. The planned amount to be increased is not less than RMB 10 million (inclusive) and not more than RMB 15 million (inclusive).

TAI KAM HLDGS (08321) issued 130 million shares of shares for sale.

CHERY AUTO (09973) February total sales of the top five brands was 146,200 vehicles, a decrease of approximately 14.8% year-on-year.

BYD COMPANY (01211) sold approximately 190,200 new energy vehicles in February.

TAI KAM HLDGS (08321) issued 130 million shares of shares for sale.

CHERY AUTO (09973) February total sales of the top five brands was 146,200 vehicles, a decrease of approximately 14.8% year-on-year.

BYD COMPANY (01211) sold approximately 190,200 new energy vehicles in February.